Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.24 EUR | -1.55% | -3.18% | -43.13% |
Apr. 09 | BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%) | |
Apr. 09 | Bastide: new contract with the British NHS | CF |
Sales 2024 * | 532M 567M | Sales 2025 * | 570M 607M | Capitalization | 113M 120M |
---|---|---|---|---|---|
Net income 2024 * | 19M 20.24M | Net income 2025 * | 22M 23.44M | EV / Sales 2024 * | 0.9 x |
Net Debt 2024 * | 367M 391M | Net Debt 2025 * | 337M 359M | EV / Sales 2025 * | 0.79 x |
P/E ratio 2024 * |
5.75
x | P/E ratio 2025 * |
5.07
x | Employees | 3,635 |
Yield 2024 * |
3.08% | Yield 2025 * |
3.84% | Free-Float | 44.92% |
1 day | -1.55% | ||
1 week | -3.18% | ||
Current month | +8.09% | ||
1 month | -15.05% | ||
3 months | -33.16% | ||
6 months | -25.84% | ||
Current year | -43.13% |
Managers | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Corporate Officer/Principal | 50 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 15.24 | -1.55% | 6,016 |
24-04-18 | 15.48 | -1.53% | 14,164 |
24-04-17 | 15.72 | -0.25% | 5,587 |
24-04-16 | 15.76 | +3.41% | 10,229 |
24-04-15 | 15.24 | -3.18% | 7,989 |
Real-time Euronext Paris, April 19, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.13% | 122M | |
-4.90% | 2.97B | |
0.00% | 1.76B | |
+4.67% | 1.56B | |
+45.83% | 597M | |
-0.97% | 507M | |
-36.14% | 356M | |
-15.25% | 138M | |
+3.85% | 68.96M |
- Stock Market
- Equities
- BLC Stock